UNSPSC 85593443: Supplement esophagus with nonautologous tissue substitute, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement esophagus with nonautologous tissue substitute, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0DU54KZ

UNSPSC 85593443 Supplement esophagus with nonautologous tissue substitute, percutaneous endoscopic approach (Commodity) shows no relevant recent state and local procurement activity. The six most-recent opportunities posted under this code are independent medical evaluation services for pension disability determinations (City of Phoenix), surgical procedure carve-out networks for city employees (City of Long Beach), occupational medical surveillance for ferry workers (Washington State Department of Transportation), emergency and specialty healthcare for detained youth (Harris County Juvenile Probation Department), pharmacy benefit management (Collier County), and temporary health professional staffing (Santa Clara County Health System). None of these solicitations involve esophageal procedures or the tissue-substitute surgical technique the code nominally describes. The mismatch between the code's clinical scope and the actual work being tagged suggests either classification error in the underlying procurement databases or that this code does not reflect current state and local spending patterns.

The geographic spread of the unrelated opportunities spans Arizona, California, Washington, Texas, and Florida, with issuing bodies ranging from city retirement offices to county health systems and state transportation agencies. Without any posting that aligns to esophageal surgical procedures or tissue substitutes, the code appears dormant for state and local procurement purposes. Firms evaluating this code should treat it as inactive and monitor whether reclassification or genuine esophageal-procedure demand emerges in future quarters.